146 related articles for article (PubMed ID: 27828874)
1. Brief Report: Soluble CD163 in CMV-Infected and CMV-Uninfected Subjects on Virologically Suppressive Antiretroviral Therapy in the ICONA Cohort.
Vita S; Lichtner M; Marchetti G; Mascia C; Merlini E; Cicconi P; Vullo V; Viale P; Costantini A; DʼArminio Monforte A;
J Acquir Immune Defic Syndr; 2017 Mar; 74(3):347-352. PubMed ID: 27828874
[TBL] [Abstract][Full Text] [Related]
2. The Association of Human Cytomegalovirus with Biomarkers of Inflammation and Immune Activation in HIV-1-Infected Women.
Lurain NS; Hanson BA; Hotton AL; Weber KM; Cohen MH; Landay AL
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):134-43. PubMed ID: 26422187
[TBL] [Abstract][Full Text] [Related]
3. Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.
Beltrán LM; Muñoz Hernández R; de Pablo Bernal RS; García Morillo JS; Egido J; Noval ML; Ferrando-Martinez S; Blanco-Colio LM; Genebat M; Villar JR; Moreno-Luna R; Moreno JA
PLoS One; 2014; 9(3):e90541. PubMed ID: 24594990
[TBL] [Abstract][Full Text] [Related]
4. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.
Knudsen TB; Ertner G; Petersen J; Møller HJ; Moestrup SK; Eugen-Olsen J; Kronborg G; Benfield T
J Infect Dis; 2016 Oct; 214(8):1198-204. PubMed ID: 27354366
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD163 and soluble CD14 plasma levels but not cellular HIV-DNA decrease during successful interferon-free anti-HCV therapy in HIV-1-HCV co-infected patients on effective combined anti-HIV treatment.
Parisi SG; Andreis S; Mengoli C; Menegotto N; Cavinato S; Scaggiante R; Andreoni M; Palù G; Basso M; Cattelan AM
Med Microbiol Immunol; 2018 Aug; 207(3-4):183-194. PubMed ID: 29523966
[TBL] [Abstract][Full Text] [Related]
6. Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection.
Burdo TH; Weiffenbach A; Woods SP; Letendre S; Ellis RJ; Williams KC
AIDS; 2013 Jun; 27(9):1387-95. PubMed ID: 23435298
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
Burdo TH; Lentz MR; Autissier P; Krishnan A; Halpern E; Letendre S; Rosenberg ES; Ellis RJ; Williams KC
J Infect Dis; 2011 Jul; 204(1):154-63. PubMed ID: 21628670
[TBL] [Abstract][Full Text] [Related]
8. CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.
Freeman ML; Mudd JC; Shive CL; Younes SA; Panigrahi S; Sieg SF; Lee SA; Hunt PW; Calabrese LH; Gianella S; Rodriguez B; Lederman MM
Clin Infect Dis; 2016 Feb; 62(3):392-6. PubMed ID: 26400999
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 1 inversely relates to monocyte/macrophage activation markers in HIV.
Fourman LT; Czerwonka N; Shaikh SD; Stanley TL; Burdo TH; Williams KC; Fitch KV; Lo J; Grinspoon SK
AIDS; 2018 Apr; 32(7):927-932. PubMed ID: 29424780
[TBL] [Abstract][Full Text] [Related]
10. Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults.
Reid M; Ma Y; Scherzer R; Price JC; French AL; Plankey MW; Grunfeld C; Tien PC
AIDS; 2017 Jan; 31(3):385-393. PubMed ID: 28081037
[TBL] [Abstract][Full Text] [Related]
11. Blood Myeloid Dendritic Cells and slanDC in Antiretroviral Therapy- Suppressed HIV-Infected Patients.
Lichtner M; Rossi R; Vita S; Savinelli S; Iannetta M; Mascia C; Marocco R; Ajassa C; Mengoni F; Scorzolini L; Maria Mastroianni C; Vullo V
Curr HIV Res; 2016; 14(4):331-9. PubMed ID: 26785889
[TBL] [Abstract][Full Text] [Related]
12. Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities.
D'Antoni ML; Byron MM; Chan P; Sailasuta N; Sacdalan C; Sithinamsuwan P; Tipsuk S; Pinyakorn S; Kroon E; Slike BM; Krebs SJ; Khadka VS; Chalermchai T; Kallianpur KJ; Robb M; Spudich S; Valcour V; Ananworanich J; Ndhlovu LC;
J Infect Dis; 2018 Sep; 218(9):1453-1463. PubMed ID: 29868826
[TBL] [Abstract][Full Text] [Related]
13. Short Communication: SCD14 and SCD163 Levels Are Correlated with VACS Index Scores: Initial Data from the Blunted Immune Recovery in CORE Patients with HIV (BIRCH) Cohort.
Williams B; Livak B; Bahk M; Keating SM; Adeyemi OM
AIDS Res Hum Retroviruses; 2016 Feb; 32(2):144-7. PubMed ID: 26366931
[TBL] [Abstract][Full Text] [Related]
14. High soluble CD163 levels correlate with disease progression and inflammation in Kenyan children with perinatal HIV-infection.
Generoso M; Álvarez P; Kravietz A; Mwamzuka M; Marshed F; Ahmed A; Khaitan A
AIDS; 2020 Jan; 34(1):33-38. PubMed ID: 31567161
[TBL] [Abstract][Full Text] [Related]
15. Brief Report: Macrophage Activation in HIV-2-Infected Patients Is Less Affected by Antiretroviral Treatment-sCD163 in HIV-1, HIV-2, and HIV-1/2 Dually Infected Patients.
Hønge BL; Andersen MN; Jespersen S; Medina C; Correira FG; Jakobsen MR; Laursen A; Erikstrup C; Møller HJ; Wejse C;
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):254-8. PubMed ID: 26825178
[TBL] [Abstract][Full Text] [Related]
16. During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Kostadinova L; Shive CL; Judge C; Zebrowski E; Compan A; Rife K; Hirsch A; Falck-Ytter Y; Schlatzer DM; Li X; Chance MR; Rodriguez B; Popkin DL; Anthony DD
J Infect Dis; 2016 Nov; 214(9):1438-1448. PubMed ID: 27540113
[TBL] [Abstract][Full Text] [Related]
17. Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda.
North CM; Muyanja D; Kakuhikire B; Tsai AC; Tracy RP; Hunt PW; Kwon DS; Christiani DC; Okello S; Siedner MJ
J Acquir Immune Defic Syndr; 2018 Aug; 78(5):543-548. PubMed ID: 29683991
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.
Burdo TH; Lo J; Abbara S; Wei J; DeLelys ME; Preffer F; Rosenberg ES; Williams KC; Grinspoon S
J Infect Dis; 2011 Oct; 204(8):1227-36. PubMed ID: 21917896
[TBL] [Abstract][Full Text] [Related]
19. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
[TBL] [Abstract][Full Text] [Related]
20. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.
Castley A; Williams L; James I; Guelfi G; Berry C; Nolan D
PLoS One; 2016; 11(6):e0158169. PubMed ID: 27355513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
